Topical Therapies for Atopic Dermatitis
Date Added:
November 12, 2023
Journal/Publication:
JAMA
Publisher:
AMA
Publication Date:
October 27, 2023
Type:
Meta-analyses, Reviews, and Guidelines
Format:
Article
DOI (1):
10.1001/jama.2023.17719
PMID (1):
37889498
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin condition affecting approximately 10% of the US population. AD often occurs as a childhood disease in conjunction with allergies and asthma, but it can also persist into or arise de novo in adulthood. AD negatively affects quality of life, social interactions, and work productivity, with annual US health care costs exceeding $5.3 billion.1 The current guideline provides recommendations on the management of AD in adults with both nonpharmacologic and pharmacologic topical therapies
Text Availability
Commercial full text (fees may apply)
RPR Commentary
A summary of current topical treatment options for atopic dermatitis. James W. Mold, MD, MPH